仙乐健康
(300791)
| 流通市值：60.44亿 | | | 总市值：72.55亿 |
| 流通股本：2.57亿 | | | 总股本：3.08亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 954,215,143.94 | 4,211,063,837.44 | 3,048,456,382.86 | 1,990,478,159.06 |
| 营业收入 | 954,215,143.94 | 4,211,063,837.44 | 3,048,456,382.86 | 1,990,478,159.06 |
| 二、营业总成本 | 898,981,704.9 | 3,893,466,402.02 | 2,813,726,698.28 | 1,825,237,477.96 |
| 营业成本 | 638,474,070.68 | 2,886,115,370.63 | 2,097,116,584.96 | 1,352,624,855.78 |
| 税金及附加 | 7,021,809.14 | 30,988,859.09 | 22,130,544.42 | 13,306,653.45 |
| 销售费用 | 89,015,123.73 | 353,203,965.03 | 232,824,240.44 | 155,861,144.7 |
| 管理费用 | 113,101,656.37 | 417,653,783.45 | 296,966,131.63 | 197,654,990.16 |
| 研发费用 | 29,103,485.1 | 125,936,900.67 | 98,626,917.14 | 67,292,784.29 |
| 财务费用 | 22,265,559.88 | 79,567,523.15 | 66,062,279.69 | 38,497,049.58 |
| 其中:利息费用 | 24,381,436.39 | 78,740,403.11 | 73,391,053.58 | 45,955,037.29 |
| 其中:利息收入 | 1,989,281.21 | 6,887,671.12 | 4,860,999.75 | 3,401,695.29 |
| 加:公允价值变动收益 | 1,556,373.71 | -21,948,964.43 | 4,287,826.08 | 2,617,963.04 |
| 加:投资收益 | 868,057.54 | -4,773,162.22 | -3,750,850.99 | -3,753,294.76 |
| 资产处置收益 | -1,477.05 | 243,157.15 | 131,961.11 | 131,961.11 |
| 资产减值损失(新) | 663,643.78 | -5,104,504.94 | -2,232,420.61 | -2,025,127.14 |
| 信用减值损失(新) | 1,879,211.35 | -913,727.34 | 146,180.3 | 1,160,332.25 |
| 其他收益 | 4,729,435.23 | 41,907,052.51 | 13,617,786.78 | 9,441,099.39 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 64,928,683.6 | 327,007,286.15 | 246,930,167.25 | 172,813,614.99 |
| 加:营业外收入 | 1,858,114.33 | 1,930,391.43 | 1,819,514.2 | 1,701,948.74 |
| 减:营业外支出 | 1,926,963.23 | 12,283,569.81 | 6,799,573.6 | 6,329,938.44 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 64,859,834.7 | 316,654,107.77 | 241,950,107.85 | 168,185,625.29 |
| 减:所得税费用 | 8,372,769.79 | 34,636,187.55 | 29,224,869.86 | 32,270,370.8 |
| 六、净利润 | 56,487,064.91 | 282,017,920.22 | 212,725,237.99 | 135,915,254.49 |
| 持续经营净利润 | 56,487,064.91 | 282,017,920.22 | 212,725,237.99 | 135,915,254.49 |
| 归属于母公司股东的净利润 | 68,640,679.6 | 325,061,746.98 | 239,801,624.33 | 154,473,292.8 |
| 少数股东损益 | -12,153,614.69 | -43,043,826.76 | -27,076,386.34 | -18,558,038.31 |
| (一)基本每股收益 | 0.29 | 1.39 | 1.34 | 0.86 |
| (二)稀释每股收益 | 0.29 | 1.39 | 1.34 | 0.86 |
| 八、其他综合收益 | 13,655,659.94 | -6,220,745.56 | -9,191,308.79 | -12,520,525.85 |
| 归属于母公司股东的其他综合收益 | 13,847,749.98 | -8,492,424.25 | -7,376,817.45 | -13,250,682.71 |
| 九、综合收益总额 | 70,142,724.85 | 275,797,174.66 | 203,533,929.2 | 123,394,728.64 |
| 归属于母公司股东的综合收益总额 | 82,488,429.58 | 316,569,322.73 | 232,424,806.88 | 141,222,610.09 |
| 归属于少数股东的综合收益总额 | -12,345,704.73 | -40,772,148.07 | -28,890,877.68 | -17,827,881.45 |
| 公告日期 | 2025-04-24 | 2025-04-18 | 2024-10-24 | 2024-08-12 |
| 审计意见(境内) | | 标准无保留意见 | | |